MedPath

Effect of Mamajjaka(Enicostemma littorale Blume) powder in the management of altered lipid profile (Medodushti)

Phase 3
Conditions
Health Condition 1: E785- Hyperlipidemia, unspecified
Registration Number
CTRI/2024/04/066176
Lead Sponsor
Ch Brahm Prakash Ayurved Charak Sansthan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with total cholesterol above 200mg/dl or patients with triglycerides above 150 mg/dl or HDL below 50 mg/dl in females and below 40 mg/dl in males or LDL above 130mg/dl, Diagnosed and confirmed patients of dyslipidemia based on investigation, Patients with one or more lakshana of Medodushti, Patients who are ready to give consent with home address and contact number, Patients who are ready to give consent with home address and contact number, Patients ready to take orally powdered medicine

Exclusion Criteria

Patient below 18 years and above 60 years of age.

Patient having illness like Tuberculosis, Carcinoma, or major illness like renal or Liver disorders.

Patients having uncontrolled Diabetes mellitus (RBS above 300 mg per dl) and Hypertension (BP above 140/90 mm per hg).

Patient having past-history of heart problem like Myocardial Infarction, Unstable angina, and congestive cardiac failure.

Pregnant females and lactating mothers.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in the hematological parameters of dyslipidemia – Lipid Profile (Total Serum Cholesterol, Serum Triglycerides, Serum LDL Cholesterol, Serum VLDL Cholesterol)Timepoint: 60 days
Secondary Outcome Measures
NameTimeMethod
Improvement in graded symptom of MedodushtiTimepoint: Day 15 <br/ ><br>Day 30 <br/ ><br>Day 45 <br/ ><br>Day 60
© Copyright 2025. All Rights Reserved by MedPath